EATRIS

We're delighted to present the EATRIS Annual Report for 2023, showcasing our activities and highlights from the past year. The report embodies the tireless efforts and dedication of the entire EATRIS community to improving patient lives. 👉 Explore the full report here: https://lnkd.in/dzpF2Bpb

#iDR25 is about bringing together all the stakeholders needed to make #DrugRepurposing a success. On 7-8 May 2025 we gather at the historic Felix Meritis in Amsterdam. Grab your ticket early and gain access to exciting sessions and key networking opportunities. 👉 Find out more & book your ticket here: https://lnkd.in/dfAXJq8d REMEDi4ALL, Beacon for Rare Diseases

EATRIS is at the Personalized Medicine Coalition conference in Boston this week. Toni Andreu (EATRIS Scientific Director) moderated a session on “Personalised Medicine: A Global Endeavour”. It was a fascinating discussion with Joshua C. Denny (CEO, All of Us Research Program, National Institutes of Health) and Monika Frenzel (International coordinator at ANR (Agence nationale de la recherche)). Big thanks to the organisers for a fantastic event!

David Morrow PhD MBA (EATRIS Senior Scientific Programme Manager) chaired a panel discussion this week at the Advanced Therapies Congress in Philadelphia on how we can address the growing skills shortage in the Advanced Therapies Medicinal Products (#ATMPs) field. 🗣️The expert panel included Stephanie Maistrellis (CEO, Lead Life Sciences), Angela Justice (Chief People Officer, Justice Group Advisors) and Craig Hasilo (CSO, CATTI), who discussed different priorities and possible solutions to entice, train and retain the next generation of experts to ensure effective delivery of ATMPs to patients. 👩💻 EATRIS launched a new online course on cell & gene therapy (ATMP) development in 2023 to make the innovative and challenging field of ATMPs more accessible for the next generation of ATMP developers (i.e. early-career biomedical PhDs, postdocs), doctors in training, clinicians and other professionals. 👉 Explore it here: https://lnkd.in/dJnscfMV #GeneTherapies #CellTherapies

The UMBRELLA_IHI project has compiled the 4 #WorldStrokeDay key takeaways from #StrokeResearch experts. The project is leading the way in innovative, data-driven & AI-powered #StrokeCare. From personalised care to recurrent stroke prevention, the project team is building a future where technology and expertise work hand-in-hand to save lives. 👉 Find out more about UMRELLA here: https://lnkd.in/gPKYZ68h

Unlock the future of medicine with us at the ADVANCE Course on Cell and Gene Therapies co-organised by #EATRIS_IT. Are you an early-career scientist? Join us in Rome on 24-27 February 2025. 👉 Find out more here: https://lnkd.in/du3SGiFd #ATMPs Istituto Superiore di Sanità

The World Health Organization (WHO) has published new guidance on best practices for #ClinicalTrials, offering the first-ever global framework for trial design and conduct. Don't miss the session with Jeremy Farrar (Chief Scientist, WHO), and Vasee Moorthy (Senior Advisor, WHO) where they’ll unpack the key insights. 👉 Register here: https://lnkd.in/dxC4xuTd

We are looking to add an Innovation Manager to our team to play a key role in translating scientific discoveries into benefits for patients. 👉 Are you a strategic thinker with a passion for advancing translational research? Apply here: https://lnkd.in/dUSAwdGi #JobAlert

Can technologies developed for particle physics tackle global health challenges? Join us at the Global Health Webinar hosted by CERN on 26 Nov 2024 to be part of this critical conversation. 🎥 Watch Sara Zullino, PhD from EATRIS talking here about Multimodal Health Data Integration for patient benefit. 👉 Register to attend at: https://lnkd.in/dbvDufiR

Last chance to register for the Advanced Therapies Congress. The event brings together over 200 speakers and 50 startups, and covers topics ranging from cutting-edge research to commercialisation strategies. 👉 Get your EATRIS discounted ticket here: https://lnkd.in/ghXGxZtm #adtherapiesUSA